Beijing Beilu Pharmaceutical Co.,Ltd.’s Net Profit Dropped 23.3% in First Quarter of 2022

Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陆药业股份有限公司) (300016.SZ) reported a net profit of 34.8 million yuan in the first quarter of 2022, down 23.3% year-on-year.

Meanwhile, the company posted 183.9 million yuan in revenue, down 17.2% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 847.7 million yuan in total liabilities, with a liability-to-asset ratio of 28.6%.